Literature DB >> 18426511

Endocannabinoids, adipose tissue and lipid metabolism.

C Pagano1, M Rossato, R Vettor.   

Abstract

Endocannabinoids regulate energy balance by modulating hypothalamic circuits controlling food intake and energy expenditure. However, convincing evidence has accumulated indicating that the endocannabinoid system is present also in peripheral tissues, in particular in adipose tissue. Fat cells produce (and are targets of) endocannabinoids. Adipogenesis, lipogenesis and glucose uptake are stimulated by endocannabinoids through CB(1) receptors and these effects are blocked by the CB(1) receptor antagonist rimonabant, suggesting that the weight-lowering effect of CB(1) receptor blockade is partly due to peripheral mechanisms. This review will focus on the role of endocannabinoids in adipose tissue metabolism, adipokine production and interactions between endocannabinoids and peroxisome proliferator activated receptors during adipogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426511     DOI: 10.1111/j.1365-2826.2008.01690.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  18 in total

1.  Photoperiodic changes in endocannabinoid levels and energetic responses to altered signalling at CB1 receptors in Siberian hamsters.

Authors:  J M Ho; N S Smith; S A Adams; H B Bradshaw; G E Demas
Journal:  J Neuroendocrinol       Date:  2012-07       Impact factor: 3.627

2.  Alteration of myocardial GRK2 produces a global metabolic phenotype.

Authors:  Benjamin P Woodall; Kenneth S Gresham; Meryl A Woodall; Mesele-Christina Valenti; Alessandro Cannavo; Jessica Pfleger; J Kurt Chuprun; Konstantinos Drosatos; Walter J Koch
Journal:  JCI Insight       Date:  2019-04-04

3.  Selective cannabinoid-1 receptor blockade benefits fatty acid and triglyceride metabolism significantly in weight-stable nonhuman primates.

Authors:  Vidya Vaidyanathan; Raul A Bastarrachea; Paul B Higgins; V Saroja Voruganti; Subhash Kamath; Nicholas V DiPatrizio; Daniele Piomelli; Anthony G Comuzzie; Elizabeth J Parks
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-03       Impact factor: 4.310

4.  Does rimonabant independently affect free fatty acid and glucose metabolism?

Authors:  Jessica Triay; Manpreet Mundi; Samuel Klein; Frederico G Toledo; Steven R Smith; Haitham Abu-Lebdeh; Michael Jensen
Journal:  J Clin Endocrinol Metab       Date:  2011-12-14       Impact factor: 5.958

5.  Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.

Authors:  Giovanni Annuzzi; Fabiana Piscitelli; Lucrezia Di Marino; Lidia Patti; Rosalba Giacco; Giuseppina Costabile; Lutgarda Bozzetto; Gabriele Riccardi; Roberta Verde; Stefania Petrosino; Angela A Rivellese; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

6.  The endocannabinoid system links gut microbiota to adipogenesis.

Authors:  Giulio G Muccioli; Damien Naslain; Fredrik Bäckhed; Christopher S Reigstad; Didier M Lambert; Nathalie M Delzenne; Patrice D Cani
Journal:  Mol Syst Biol       Date:  2010-07       Impact factor: 11.429

7.  Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.

Authors:  Angelo A Izzo; Fabiana Piscitelli; Raffaele Capasso; Gabriella Aviello; Barbara Romano; Francesca Borrelli; Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

Review 8.  The endocannabinoid system: potential for reducing cardiometabolic risk.

Authors:  Henry N Ginsberg; Stephen C Woods
Journal:  Obesity (Silver Spring)       Date:  2009-04-16       Impact factor: 5.002

9.  Plasma fatty acid ethanolamides are associated with postprandial triglycerides, ApoCIII, and ApoE in humans consuming a high-fructose corn syrup-sweetened beverage.

Authors:  Candice Allister Price; Donovan A Argueta; Valentina Medici; Andrew A Bremer; Vivien Lee; Marinelle V Nunez; Guoxia X Chen; Nancy L Keim; Peter J Havel; Kimber L Stanhope; Nicholas V DiPatrizio
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-04-10       Impact factor: 4.310

Review 10.  The endocannabinoid system in the adipose organ.

Authors:  Kwang-Mook Jung; Lin Lin; Daniele Piomelli
Journal:  Rev Endocr Metab Disord       Date:  2021-01-02       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.